Epilepsy affects at least 50 million people worldwide, and the available treatment is associated with various side effects. Approximately 20-30% of the patients develop seizures that persist despite careful monitored treatment with antiepileptic drugs. Thus, there is a clear need for the development of new antiepileptic drugs, and the venoms can be an excellent source of probes. In this context, while there are studies on venoms from snakes, scorpions, and spiders, little is known regarding venom from ants. The aim of this study was to investigate the potential pro-and anticonvulsant effects of the venom from the ant Dinoponera quadriceps (Kempf) in Swiss mice. After the injection of the crude venom (DqTx-5, 50, and 500 mg/mL) in the lateral ventricle of mice, we observed a reduction of exploration and grooming behaviors, as well as an increase in immobility duration. In addition, the crude venom induced procursive behavior and tonicclonic seizures at the highest concentration. Conversely, the preadministration of the denatured venom (AbDq) at the concentration of 2 mg/mL protected the animals against tonic-clonic seizures (66.7%) and death (100%) induced by administration of bicuculline. Taken together, the findings demonstrate that D. quadriceps venom might be potential source of new pro-and anticonvulsants molecules.
Introduction
Epilepsy is an episodic disorder of the nervous system resulting from the excessive synchronous and sustained discharge of a group of neurons (Bai et al 2006) . This disorder affects at least 50 million people worldwide, and approximately 20-30% of the patients develop a chronic epilepsy, in which the seizures persist despite careful monitored treatment with antiepileptic drugs (Löscher 1997) . Further, patients who use antiepileptic drugs frequently suffer from collateral effects such as gastric discomfort, sedation, diplopia, ataxia, nystagmus, gingival hypertrophy, hirsutism, cognitive impairment, behavior disturbances, as well as idiosyncratic reactions such as rash, agranulocytosis, hepatic failure, and aplastic anemia (Mortari et al 2007) . Thus, there is a clear need for the development of new antiepileptic drugs that could treat the pharmacoresistant cases and/or induce less adverse effects.
Possible sources of substances with this profile are invertebrate venoms (Mortari et al 2007) . They have a considerable amount of bioactive compounds, which have showed pharmacological effects on several biological systems (Rodrigues et al 2001 , Beleboni et al 2004 , Rajendra et al 2004 . It is known that toxins isolated from animal venoms can exert neurophysiological effects. Some of them present high affinity to receptors, ionic channels, and transporters in the central nervous system (Beleboni et al 2004 , Mellor & Usherwood 2004 , Wang & Chi 2004 . It is estimated that only a small part of this biodiversity has been scientifically explored, and most studies have focused on the structurefunction relationship of these neurotoxins in vitro (Mortari et al 2007) .
Some studies have focused in the possible pro and anticonvulsant action of these venoms and/or their active compounds. The crude venom of the spider Parawixia bistriata Rengger induced the appearance of limbic seizures (Rodrigues et al 2001) when administered intracerebroventricularly in rats. Oliveira et al (2013) showed the intraperitoneal (i.p.) injection of Tityus serrulatus Lutz & Mello venom in mice elicited spasms and convulsions preceded by intense salivation. Further, compounds isolated from venoms can also elicit seizures in rodents. For example, the BmK I, an alpha-like scorpion neurotoxin isolated from the venom of Buthus martensi Karsch, induced seizures in rats by intrahippocampal administration (Bai et al 2006) . Moreover, the TsTX-I, a scorpion neurotoxin isolated from T. serrulatus venom, promoted short and long epileptic-like discharges when injected in the hippocampus of rats (Teixeira et al 2010) .
On the other hand, conversely, to the proconvulsant action of the P. bistriata spider crude venom, toxins isolated from this venom, such as Parawixin 10, blocked generalized seizures induced by kainic acid, N-methyl-D-aspartate, and pentylenetetrazole in rats (Fachim et al 2011) . In addition, Parawixin 2 is a potent anticonvulsant against chemically induced acute seizures (Liberato et al 2006 , Gelfuso et al 2007 , and showed similar effects against pentylenetetrazol (PTZ)-induced kindling (Gelfuso et al 2013) . Further, besides the effects of their isolated toxins, the denatured crude venoms, i.e., venom free of high molecular weight proteins, have also showed anticonvulsant actions. The denatured crude venom of the solitary spider Scaptocosa raptoria Roewer protected rats against seizures evoked by the administration of bicuculline in the area tempestas when injected bilaterally into substantia nigra pars reticulate (SNpr). The SrTx1.3 toxin isolated from this venom was also capable of protecting rats against seizures induced by the administration of bicuculline in the area tempestas when administrated in the SNpr (Mussi- Ribeiro et al 2004) . Likewise, Cunha et al (2005) showed that lower doses of the crude venom of the wasp Polybia ignobilis Haliday via intracerebroventricular (i.c.v.) provoked severe generalized tonic-clonic seizures. Conversely, the denatured venom protected the animals against acute seizures induced by microinjections of bicuculline, picrotoxin, and kainic acid. In this context, it is extremely important to know the effects of animal venoms on the central nervous system because venom neurotoxins appear as potential candidates for new anticonvulsant drugs.
The ants are members of the Hymenoptera, which also comprises bees, wasps, and hornets. Despite the more than 35,000 species of ants known (Fitzgerald & Flood 2006 , Taxonomic List -Ants of All Antweb (Species) (2012)), few studies have explored the potential biological effects of ant venoms. One example is the Poneratoxin, a neuropeptide isolated from the venom of the ant Paraponera clavata Fabricius. This toxin blocked the synaptic transmission in the central nervous system of cockroaches (Piek et al 1991) and sodium channels in frog skeletal muscle fibers (Duval et al 1992) . In addition, the Ectatomin toxin isolated from the venom of the ant Ectatomma tuberculatum Olivier can inhibit calcium currents in ventricular myocytes of rats (Pluzhnikov et al 1999) .
Relevant to the present study, the Ponerinae subfamily includes the genus Dinoponera Roger a primitive group of large ants that can provoke extremely painful stings and potential systemic manifestations such as fever, tremor, cold sweating, nausea, vomiting, lymphadenopathy, and cardiac arrhythmias (Haddad Junior et al 2005) . Dinoponera quadriceps (Kempf) is a queenless Ponerinae ant found in the Northeastern Brazil (Medeiros et al 2012) . Because very few studies have focused on the venoms of ants as sources of excitatory and inhibitory neuronal modulators, the aim of this study was to investigate the effects of the intracerebroventricular injection of the D. quadriceps ant venom on mice behavior in the open field. Considering the fact that the crude venom from invertebrates sometimes induces seizures when tested in rodents whereas the denatured venom causes the opposite effect (Cairrão et al 2002 , Cunha et al 2005 , we also evaluated the anticonvulsant potential of the denatured venom on seizures induced by the administration of bicuculline in mice.
Material and Methods

Ant collection and venom preparation
Ants were collected in an area of the Atlantic Forest (6°5′S, 35°12′W) located in Nísia Floresta city, state of Rio Grande do Norte (Northeastern Brazil). To collect the venom, ants were first euthanized by freezing at −20°C, and venom reservoirs were dissected out. Two hundred venom reservoirs were homogenized in 2 mL of distilled water and centrifuged at 5000g for 10 min. The supernatant (crude venom-DqTx) was lyophilized overnight and stored at −20°C. The crude extract was freshly dissolved in saline solution at different concentrations (5, 50, and 500 mg/mL). Afterwards, 1:1 acetonitrile-water (ACN/H 2 O) was added to the crude venom to prepare the acetonitrile-boiled D. quadriceps crude venom (AbDq). This solution was centrifuged at 5000g for 10 min. The supernatant was boiled for 10 min and centrifuged. The final supernatant was dissolved in saline solution at different concentrations (2, 4, and 6 mg/mL).
Subjects
Male and female Swiss mice (3-5 months, 30-50 g) were used. Groups of 5-6 animals were kept in plastic cages (20×30×13 cm) under conditions of acoustic isolation and controlled temperature (25±1°C), with a 12:12 h photoperiod (lights on 6:30 a.m.). Food and water were available ad libitum. Mice were handled in accordance with the guidelines of the Brazilian law for the use of animals in research (Law Number 11.794), and all procedures were approved by the local ethics committee. All efforts were made to minimize animal potential pain, suffering, or discomfort.
Surgery
Mice were anesthetized with ketamine (100 mg/kg i.p.) plus xylazine (10 mg/kg i.p.) and fixed in the stereotaxic frame (Insight, Brazil). A stainless-steel guide cannula (25 gage, 8 mm length) was implanted in the lateral ventricle. The stereotaxic coordinates for the guide cannula placement were 0.6 mm posterior from the bregma, −1.1 mm lateral from the midline, and 1.0 mm ventral from the surface of the brain according to the mice atlas (Paxinos & Franklin 2008) . Before surgical incision, 0.1 mL of 2% lidocaine was injected percutaneously. The guide cannula was anchored to the skull with screws and dental acrylic. At the end of the surgery, the cannula was temporarily sealed with a stainlesssteel wire to avoid obstruction. The animals were given 5-7 days of postoperative recovery prior to the start of the experimental proceedings.
Behavioral analysis
Primary screening with crude venom. The animals received an intraventricular injection of saline (CRT) or the crude venom at a rate of 0.5 μL/min to a final volume of 1 μL via a microsyringe pump (Insight, Brazil) with a 10-μL syringe (Hamilton Co., USA) connected to an injection needle. The injection needle was left in the guide cannula for additional 60 s following infusion to allow the drug to diffuse from the needle tip. Immediately after the administration, animals were placed in a circular arena (30 cm in diameter and 60 cm high) located in an experimental room illuminated by a 40-W fluorescent lamp (at the arena floor level) for 20 min. The behavioral session was recorded by a digital camera placed above the apparatus, and the behavioral parameters were registered.
The animals were randomly assigned to control (CRT, n= 9) or one of three experimental groups that received 5 (n=9), 50 (n=10), or 500 mg/mL (n=10) of the DqTx. We quantified the time spent in the following behavioral clusters: exploration (behaviors such as exploratory sniffing, walking, scanning, and erect posture); grooming (grooming of the head, snout, claws, and back); immobility (time of complete absence of movements, except breathing); procursive seizures (myoclonic jerks of paws, running, and gyrating); and tonic-clonic seizures (behaviors such as jumping, rearing, and atonic falling).
Anticonvulsant assay. The concentration of the chemical convulsant GABA A receptor antagonist bicuculline, 10 mg/ mL (Sigma, USA), was standardized in order to provoke tonic-clonic seizures in 100% of injected animals in less than 30 min (BIC group). Animals were randomly divided into the following groups: CRT (n=8); animals that were injected with saline solution 20 min prior to bicuculline administration; animals that were injected with AbDq2 (n=6), AbDq4 (n= 6), or AbDq6 (n =6); and animals that were injected with AbDq2 (n=8), AbDq 4 (n=9), or AbDq6 mg/mL (n=8) 20 min prior bicuculline administration in the left lateral ventricle. Drugs and venom concentrations were injected as explained in the previous section (see Surgery session). Immediately after the administration of bicuculline, animals were placed in the open field, and behavior was registered for 30 min.
The severity of seizures was evaluated using an adapted Racine's scale (Racine 1972) , as follows: 1-myoclonic jerks of contralateral paw, 2-mild paw clonus lasting at least 5 s, 3-severe paw clonus lasting at least 15 s, 4-rearing in addition to severe paw clonus, 5-rearing and falling in addition to severe paw clonus. Moreover, percentage of tonic-clonic seizures and deaths was evaluated.
Verification of the injection site. Upon completion of the behavioral procedures, mice were euthanized with an intraperitoneal injection of sodium thiopental (50 mg/kg) and injected i.c.v. with 1 μL of methylene blue stain to mark the correct site on injection. Brains were removed and manually cut to check the position of the cannula. Only animals with correct injection sites were included in the analysis. The same procedure was held if the death occurred before the end of the experiments.
Statistical analysis
Data normality and the homogeneity of variances were, respectively, tested by the Shapiro-Wilk and Levene's tests. Comparisons among different concentrations of the ant venom in relation to behavioral clusters were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. The number of protected animals in the anticonvulsant assays was analyzed using χ 2 test followed by residual analysis, and the difference between means of score in these assays was analyzed using Mann-Whitney test with Bonferroni correction. We considered p<0.05 as significant values. All statistical analyses were conducted with PASW Statistics 18 software (IBM, USA).
Results
Primary screening with crude venom
One-way ANOVA revealed a significant effect of treatment for the exploratory activity (F 3, 37 =17.43, p<0.001). The groups that received different concentrations of ant venom (DqTx) showed reduction of the time spent in exploratory activities, with post hoc analysis detecting a significant difference at the highest concentration (DqTx 500 mg/mL) (p<0.001) (Fig 1a) .
Significant effects of treatment were also observed for the grooming cluster (F 3, 37 =11.74, p<0.001). There was a reduction of these behaviors in groups that received the DqTx, reaching significant values at the highest concentration according to Tukey's post hoc test (p=0.006) (Fig 1b) .
One-way ANOVA also revealed a treatment effect for the immobility (F 3, 37 =9.54, p<0.001). The group that received saline barely displayed immobility, whereas the animals treated with DqTx 50 and 500 mg/mL showed increased immobility duration. Tukey's post hoc test showed a tendency for the DqTx 50 (p=0.07) and a significant difference for the DqTx 500 (p<0.001) (Fig 1c) .
The analysis of the percentage of time spent in procursive seizures revealed significant effects for treatment (F 3, 37 = 4.32, p<0.05), but this behavioral cluster only appeared at 50 and 500 mg/mL, and Tukey's post hoc test showed a significant difference between control and DqTx 500 (p<0.05) (Fig 1d) . Moreover, the highest concentration of the venom (DqTx 500) promoted tonic-clonic seizures (6.23±3.9%, p<0.05) (Fig 1e) .
Procursive seizures appeared in three mice after administration of the DqTx 50 whereas the DqTx 500 provoked these seizures in eight animals (Table 1 ). In addition, the intermediate concentration (DqTx 50) promoted the death of two animals, while four animals died as a consequence of the administration of DqTx 500 mg/mL (Table 1) .
Anticonvulsant assay
All animals that received saline solution prior to bicuculline administration presented tonic-clonic seizures (level 5) followed by death. Conversely, animals that received different concentrations of AbDq did not present seizures or other seizure-related behaviors ( Table 2) .
The administration of 2 mg/mL AbDq prior to bicuculline significantly reduced the median score of the seizures from 5 to 3 (U=12, p<0.008) ( Table 2 ) and also protected 66.7% of the animals against tonic-clonic seizures (χ 2 3 = 10.943, p<0.05, residual p<0.05) (Fig 2a) as well as 100% of the animals against death (χ 2 3 = 16.985, p = 0.001, residual p<0.05) (Fig 2b) . The other concentrations of the AbDq did not change the median score, but these treatments decreased the number of animals showing higher score seizures (Table 2) . Furthermore, 4 and 6 mg/mL AbDq protected 12.5 and 25.0% of the animals against tonic-clonic seizures, respectively. Moreover, 4 and 6 mg/mL AbDq protected 50% of the animals against death (Fig 2b) .
Discussion
We demonstrated that the crude venom of D. quadriceps promotes behavioral alterations in mice, such as reduction of exploration and grooming behaviors and increasing of immobility. Furthermore, at the highest concentrations (50 and 500 mg/mL), the venom induced procursive and tonic-clonic seizures. However, the previous administration of the denatured venom protected the animals against tonic-clonic seizures and death induced by administration of the convulsant bicuculline.
In general, the chemoconvulsants cause seizures through two basic mechanisms, i.e., the facilitation of excitatory neurotransmission or the inhibition of the inhibitory neurotransmission. The convulsants pentylenetetrazol (PTZ), bicuculline, and picrotoxin block the inhibitory neurotransmission mediated by GABA, acting on the same site of the neurotransmitter (bicuculline and PTZ) or through action on a modulatory biding site at the receptor (picrotoxin) (Ramanjaneyulu & Ticku 1984) . Conversely, the kainic acid and NMDA agonists increase the excitatory neurotransmission by acting on their specific receptors, leading to massive neuronal depolarization, and increase in inward ion currents, such as Na + and Ca
2+
. Studies have showed that venoms from invertebrates can elicit epileptic-like seizures in rodents. As mentioned, the BmK I and TsTX-I neurotoxins from scorpions induce seizures in rats, both acting in sodium channels. In this context, it is possible that the crude venom of D. quadriceps ant contains neurotoxins that can act in some of these mechanisms.
The crude venom of the spider S. raptoria caused changes in animal behavior characterized by a initial period of freezing followed by an explosion of a behavior similar to wild running (similar the procursive seizures), which can precede tonicclonic seizures, when administered in the lateral ventricle of rats (Ribeiro et al 2000) . However, the denatured venom from the same spider was capable of protecting animals from seizures induced by PTZ and bicuculline when injected in the lateral ventricle of rats (Cairrão et al 2002) . Similar results were observed for the venom of the spider P. bistriata, which induced limbic seizures when injected in the lateral ventricle of rats (Rodrigues et al 2001) , but protected animals against seizures induced by PTZ, picrotoxin, and bicuculline when denatured (Cairrão et al 2002) . Similar to the pattern observed with the venoms of S. raptoria and P. bistriata, we showed that the venom of D. quadriceps also promoted an increased .07 compared to control (one-way ANOVA followed by Tukey's post hoc test). period of immobility, followed by procursive and/or tonicclonic seizures. Thus, we can propose that convulsive activity induced by D. quadriceps venom is due to high weight molecules, such as protein or enzymes, which probably lose their three-dimensional conformation and, consequently, their activity when the venom is denatured.
From another standpoint, the classic antiepileptic drugs act through three basic mechanisms: modulation of voltage-dependent ion channels, decreasing the excitatory transmission, or increasing the GABA-mediated inhibitory neurotransmission (Kwan et al 2001 , Porter et al 2012 .
Voltage-dependent ion channels (Na + , Ca
, or K + ) are important in the neurotransmission by participation of neuronal action potential; thus, modulating the opening of these channels may reduce the excess of excitatory transmission. The sodium channels are responsible for the upstroke of neuronal action potential; thus, blocking these channels may reduce the excess of excitatory transmission in epileptic patients. The calcium channels are involved in the neurotransmitter release, and their blocking would reduce the neurotransmission. Lastly, the potassium channels are responsible for repolarization of the membrane, and its direct activation hyperpolarizes the neuronal membrane, consequently limiting the firing of action potentials (Kwan et al 2001 , Duncan et al 2006 , Porter et al 2012 . Some venom toxins with anticonvulsant potential act on these voltage-dependent ion channels. The alpha-type neurotoxins BmK IT2 and BmK AS are sodium channels modulators (Zhao et al 2008 (Zhao et al , 2011 , and the ω-conotoxins GVIA and MVIIA are N-type calcium channel antagonists (Gasior et al 2007) .
The majority of the excitatory synapses in human brain are mediated by L-glutamate; thereby, it is a rational target for anticonvulsant drug design. However, none of the commonly used antiepileptic drugs exert their effects solely by action on the glutamate system given the wide range of side effects. Notwithstanding, this mechanism is believed to be involved in the activity of some antiepileptic drugs (Macdonald & Kelly 1995 , Kwan et al 2001 , Mortari et al 2007 . An example of venom toxin with anticonvulsant potential whose mechanism of action includes modulation of glutamatergic transmission is the Parawixin 10, which increases glutamate uptake (Fachim et al 2011) .
There are several antiepileptic drugs that act on the GABA A receptor, enhancing the action of GABA or acting as agonists. Moreover, other drugs inhibit the uptake of GABA, increasing its availability in the synaptic cleft (Dalby 2000, Duncan et al 2006 , Rogawski 2006 . This last mechanism is the case of the aforementioned toxins SrTx1 and FrPbA2, isolated from the venom of the spiders S. raptoria and P. bistriata, respectively (Cairrão et al 2002) . Several other studies on invertebrate venoms have showed the anticonvulsant and neuroprotective activities of compounds in several animal models of seizure induction and neuronal damage (see Rajendra et al 2004 , Mortari et al 2007 . This inhibitory activity might be attributed to the selective antagonism of glutamatergic receptors (conantoxin-L; Jimenez et al 2002), blockage of Na + channels (BmK AS toxin; Zhao et al 2011), blockage of Ca 2+ channels (omega-conotoxin MVIIC and omega-agatoxin IVA; Jackson & Scheideler 1996) , inhibition of glutamate release (PnTx3-6 toxin; Vieira et al 2003) , enhancement of glutamate transporters (Fontana et al 2003 (Fontana et al , 2007 , or the inhibition of GABA and glycine transporters (Parawixin 1; Beleboni et al 2006) .
Given the proconvulsant action of bicuculline is due to GABA A receptor antagonism; one possible explanation to our data could be the increased availability of GABA due to an effective blockage of neuronal or glial GABA uptake. Despite the large relative amount of proteins usually present in invertebrate venoms, the majority of neurobiological effects are related to small peptides and low molecular weight compounds, such as acyl polyamines (Beleboni et al 2004 , Mortari et al 2007 . These compounds are not removed in the denaturation process; thereby, they may be responsible for the neuroprotective effects showed by the venom of D. quadriceps. Despite the evidence of possible mode of mechanisms of the molecules in this venom, isolation and purification of fractions and activity testing at the cellular level are still required to obtain conclusive data on their mode of action.
Recently, Lopes et al (2013) reported the neuroprotective effect of the venom of D. quadriceps through i.p. injection in the model of seizures induced by PTZ and an opposite effect when the venom was injected e.v. The differences observed could be related to differences in the experimental procedures when compared with our data. They used i.p. and e.v. as administration routes, while we opted to investigate the effects of the venom injected directly into the brain. Moreover, we tested both the crude and the denatured forms of the venom, and added an overall analysis of behavioral changes caused by the venom administration in mice. Finally, we used a different pharmacological model to induce the seizures. In this respect, that study showed that the venom was effective in reducing seizures induced by PTZ (a GABA A receptor antagonist), but not by pilocarpine and strychnine. These findings corroborate our results, strengthening the idea that the mode of action of the venom involves the GABAergic transmission.
In summary, this work is one of the few in vivo studies on the effects of ant venoms on the neurological system of vertebrates. Although a GABA-related mechanism is suggested, further research is needed to understand the basis of the anticonvulsant effect of the D. quadriceps venom. Thus, further work will deal with the isolation and determination of the structure of the active components from this ant venom as well as clarify their mode of action.
